Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wan-Yu He"'
Publikováno v:
Kidney & Blood Pressure Research, Vol 43, Iss 1, Pp 287-295 (2018)
Background/Aims: Vascular calcification, which involves an active cellular transformation of vascular smooth muscle cells into bone forming cells, is prevalent and predicts mortality in dialysis patients. Its mechanisms are complex and unclear. We pr
Externí odkaz:
https://doaj.org/article/5aad91a350694e708e6ba29f2402ea89
Autor:
Wan-Yu He, Fei Wu, Xin-Xin Pang, Guan-Jong Chen, La-Ta A, Lian He, Song Wang, Chao-Shu Tang, Ai-Hua Zhang
Publikováno v:
Kidney & Blood Pressure Research, Vol 41, Iss 1, Pp 78-85 (2016)
Aims/Introduction: Irisin is a newly identified myokine which can promote energy expenditure. Urotensin II (UII) is identified as the most potent mammalian vasoconstrictor to date. Previous studies showed that UII can aggravate insulin resistance whi
Externí odkaz:
https://doaj.org/article/ad3099ed866b44bb8ef5d4aebeb4ea7d
Publikováno v:
In Thin-Walled Structures February 2019 135:537-547
Publikováno v:
In European Journal of Mechanics / A Solids November-December 2017 66:55-68
Publikováno v:
Kidney & Blood Pressure Research, Vol 43, Iss 1, Pp 287-295 (2018)
Background/Aims: Vascular calcification, which involves an active cellular transformation of vascular smooth muscle cells into bone forming cells, is prevalent and predicts mortality in dialysis patients. Its mechanisms are complex and unclear. We pr
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Irisin is a newly identified myokine that can promote energy expenditure. Previous studies showed that circulating urotensin II (UII) levels were increased in diabetes, and UII could inhibit the glucose transport in skeletal muscle
Autor:
Song Wang, Guan-Jong Chen, Ai-Hua Zhang, Chao-Shu Tang, La-Ta A, Lian He, Wan-Yu He, Fei Wu, Xinxin Pang
Publikováno v:
Kidney & Blood Pressure Research, Vol 41, Iss 1, Pp 78-85 (2016)
Aims/Introduction: Irisin is a newly identified myokine which can promote energy expenditure. Urotensin II (UII) is identified as the most potent mammalian vasoconstrictor to date. Previous studies showed that UII can aggravate insulin resistance whi